Nasal delivery progesterone powder formulations comparison with oral administration.
Provasi
D
D
Pharmaceutical Department, Parma, Italy.
De Ascentiis
A
A
Minutello
A
A
Colombo
P
P
Catellani
P L
PL
D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D003505:Cyclodextrins; D008297:Male; D011208:Powders; D011374:Progesterone / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011817:Rabbits; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D011208:Powders; D047392:beta-Cyclodextrins; D011374:Progesterone; C031215:betadex